Endovascular Today3d
Medtronic’s VenaSeal Closure Compared to Surgical Stripping in 6-Month Data
Secondary outcomes through 6 months were reported from the VenaSeal Spectrum Surgical Stripping study, a randomized ...
Endovascular Today2d
Medtronic Presents Studies on Utility of Atherectomy to Treat PAD
Medtronic announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.
Endovascular Today3d
Endovascular Engineering’s Helo PE Thrombectomy System Evaluated in Pilot ENGULF Trial
Julie Bulman, MD, presented the results of the pilot ENGULF trial. The two-phase, prospective, single-arm study assessed the ...
Endovascular Today1d
Philips Begins Pivotal THOR Trial of Combined Device to Treat PAD
Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...
Endovascular Today3d
Medtronic’s ABRE Study Subanalysis Shows Obesity Paradox After Iliac Vein Stenting
Medtronic recently announced results from a subset analysis of the ABRE study showing an obesity paradox reflected in outcomes ...
Endovascular Today5d
CMS Grants TPT Payment for Medtronic’s Symplicity Spyral RDN and Recor’s Paradise uRDN Systems
Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...
Endovascular Today11d
Jupiter Endovascular Commences Vertex System’s SPIRARE II US Pivotal Trial
Jupiter Endovascular, Inc. announced that the first patient has been treated in the SPIRARE II United States pivotal study of ...
Endovascular Today6d
Merit Medical’s Siege Vascular Plug Launched in United States
Merit Medical Systems, Inc. recently announced the United States launch of its Siege vascular plug, which received FDA 510(k) ...
Endovascular Today4d
Surmodics’ Pounce Thrombectomy System Evaluated in Infrainguinal Subset From PROWL Registry
Surmodics, Inc. recently announced early results from its PROWL registry study of a subset of 60 real-world patients with acute ...
Endovascular Today9d
Medtronic’s Symplicity Spyral RDN Evaluated at 2 Years in SPYRAL HTN-ON MED
Medtronic announced new long-term data from the SPYRAL HTN-ON MED clinical trial of the company’s Symplicity Spyral renal ...
Endovascular Today8d
PEERLESS RCT Compares Large-Bore Mechanical Thrombectomy to CDT for Intermediate-Risk PE
Findings were presented from the international PEERLESS randomized controlled trial comparing patient outcomes after ...
Endovascular Today8d
Cook’s Zilver Vena Stent Shows Sustained High Patency in 3-Year VIVO Study Results
Cook Medical announced that findings from the VIVO clinical study of the company’s Zilver Vena venous self-expanding sten ...